Further study on EMMPRIN and HER-2 inhibitors may serve as a new approach for inhibiting the invasion and metastasis of papillary thyroid carcinoma and, most significantly, may improve the prognosis of patients with papillary thyroid carcinoma. Here, ERBB2 is linked to differentiated thyroid carcinoma.